Episode 217: Vadim Koshkin in the Rising Star Series

Vadim Koshkin, MD, talks about the prevalence of HER2 expression in bladder and urothelial cancers, along with his recent work on the UNITE study on the efficacy of enfortumab vedotin for advanced urothelial cancer and other antibody drug conjugates.
Dr. Koshkin is an oncologist and assistant professor at University of California San Francisco, with a focus on GU malignancies and bladder cancer.